4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-23-028214
Chief Operating Officer acquired 250,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lecault Veronique Chief Operating Officer | 2023-05-05 | Option exercise | +250,000 | $0.19 | $47,500 | 2,020,122 | D |
| Derivatives | |||||||
| Lecault Veronique Chief Operating Officer | 2023-05-05 | Option exercise · Share option (right to buy) | −250,000 | 3,142,689 | D | ||
Loading xslF345X04/doc4.xml…